MORPHINE SULFATE INJECTION USP
STERINOVA INC.
Quick answers
Is there a shortage of MORPHINE SULFATE INJECTION USP in Canada?
No. There is no current shortage of MORPHINE SULFATE INJECTION USP 100MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
ORAMORPH SR TABLETS 100MG
Extended-ReleaseROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
MORPHINE SULFATE INJ 10MG/ML USP
SANDOZ CANADA INCORPORATED
MORPHINE SULFATE INJ 15MG/ML USP
SANDOZ CANADA INCORPORATED
MORPHINE HP 50
SANDOZ CANADA INCORPORATED
MORPHINE HP 25 - 25MG/ML
SANDOZ CANADA INCORPORATED
MORPHINE LP EPIDURAL
SANDOZ CANADA INCORPORATED
DIN
02491931
Strength
100MG
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from STERINOVA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
5000UNIT · DIN 02456958
40MG · DIN 02485540
20MG · DIN 02561603
20MG · DIN 02485532
10MG · DIN 02481979
1MG · DIN 02498022
0.4MG · DIN 02548194
50MG · DIN 02451883
9MG · DIN 02560100
100% · DIN 02542145